supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 4 years ago
supplement:
Methionine
drug:
Xl184
Research Papers that Mention the Interaction
“127 Background: XL184 is an oral, potent inhibitor of MET and VEGFR2.”
Phase II study of XL184 in a cohort of patients (pts) with castration-resistant prostate cancer (CRPC) and measurable soft tissue disease.“2047 Background: XL184 is a potent orally bioavailable inhibitor of MET , RET, KIT, and VEGFR2.”
“2049 Background: XL184 is an oral inhibitor of MET , RET, KIT, and VEGFR-2 with potent antitumor effects in preclinical models of GBM.”
“ XL184 is a potent orally bioavailable inhibitor of MET , RET, KIT, and VEGFR2; MET and VEGFR2 have been shown to play important roles in tumor angiogenesis.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback